Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 060569
Company: CHARTWELL RX

Products on ANDA 060569

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
FULVICIN-U/F	GRISEOFULVIN, MICROSIZE	500MG	TABLET;ORAL	Prescription	AB	No	No
FULVICIN-U/F	GRISEOFULVIN, MICROSIZE	250MG	TABLET;ORAL	Prescription	AB	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 060569

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
09/09/1971	ORIG-1	Approval				Label is not available on this site.

Supplements

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
01/26/2001	SUPPL-7	Manufacturing (CMC)-Control		Label is not available on this site.

Therapeutic Equivalents for ANDA 060569

FULVICIN-U/F

TABLET;ORAL; 500MG
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
FULVICIN-U/F	GRISEOFULVIN, MICROSIZE	500MG	TABLET;ORAL	Prescription	No	AB	060569	CHARTWELL RX
GRISEOFULVIN	GRISEOFULVIN, MICROSIZE	500MG	TABLET;ORAL	Prescription	No	AB	091592	SANDOZ
GRISEOFULVIN	GRISEOFULVIN, MICROSIZE	500MG	TABLET;ORAL	Prescription	No	AB	202482	SIGMAPHARM LABS LLC

TABLET;ORAL; 250MG
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
FULVICIN-U/F	GRISEOFULVIN, MICROSIZE	250MG	TABLET;ORAL	Prescription	No	AB	060569	CHARTWELL RX
GRISEOFULVIN	GRISEOFULVIN, MICROSIZE	250MG	TABLET;ORAL	Prescription	No	AB	091592	SANDOZ